Volume | 16,045 |
|
|||||
News | - | ||||||
Day High | 0.399 | Low High |
|||||
Day Low | 0.382946 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Shuttle Pharmaceuticals Holdings Inc | SHPH | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.399 | 0.382946 | 0.399 | 0.39228 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
47 | 16,045 | US$ 0.3940762 | US$ 6,323 | - | 0.35 - 2.75 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
14:07:55 | 30 | US$ 0.395 | USD |
Shuttle Pharmaceuticals Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
6.24M | 16.00M | - | 0 | -6.59M | -0.41 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Shuttle Pharmaceuticals News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SHPH Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.387 | 0.4299 | 0.3705 | 0.3898058 | 20,744 | 0.008 | 2.07% |
1 Month | 0.4224 | 0.4399 | 0.3705 | 0.4145164 | 31,326 | -0.0274 | -6.49% |
3 Months | 0.3825 | 0.545 | 0.35 | 0.4133809 | 51,231 | 0.0125 | 3.27% |
6 Months | 0.49 | 0.6183 | 0.35 | 0.4654025 | 106,289 | -0.095 | -19.39% |
1 Year | 1.66 | 2.75 | 0.35 | 1.26 | 463,050 | -1.27 | -76.20% |
3 Years | 24.05 | 126.26 | 0.35 | 7.55 | 854,671 | -23.66 | -98.36% |
5 Years | 24.05 | 126.26 | 0.35 | 7.55 | 854,671 | -23.66 | -98.36% |
Shuttle Pharmaceuticals Description
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy. |